| نویسندگان | نسرین صابری هارونی,فاطمه دهقانی تفتی,نازنین مقدم,حسین نعیمی,پریسا آذرنگ,آذر تحقیقی |
| نشریه | Research on Chemical Intermadiate |
| شماره صفحات | 1 |
| شماره مجلد | 2 |
| ضریب تاثیر (IF) | 2.8 |
| نوع مقاله | Full Paper |
| تاریخ انتشار | 2024-07-03 |
| رتبه نشریه | علمی - پژوهشی |
| نوع نشریه | الکترونیکی |
| کشور محل چاپ | ایران |
| نمایه نشریه | JCR ,SCOPUS |
چکیده مقاله
Discovering new and effective medications against resistant bacteria is an urgent
need to save modern medicine, as well as prevent and treat life-threatening diseases.
This study aimed to synthesize a series of pyrano[2,3-d]pyrimidinone derivatives
using a Tandem Knoevenagel-Michael cyclocondensation reaction. All the synthetic
compounds were screened for antibacterial activity against various bacterial
strains and isolates. Compound 7‐amino‐6‐cyano‐5-(5-nitrofuran-2-yl)‐pyrano[2,3-
d]pyrimidin‐(1H,3H)-2,4‐diones (4s) showed superb antibacterial activities against
Staphylococcus aureus, Bacillus subtilis, and Escherichia coli with a minimum
inhibitory concentration (MIC) ranging from 3.91 to 7.81 μg/mL. This compound
also exhibited more potent antibacterial activity than levofloxacin against methicillin-
resistant S. aureus (MRSA) with a MIC value of 3.91 μg/mL and demonstrated
relatively no cytotoxicity at the mentioned MIC concentration. Field-emission scanning
electron microscopy (FE-SEM) confirmed the complete damage of S. aureus
and E. coli following exposure to compound 4s. The compound 4s has the potential
to be used as an alternative antibacterial drug after supplementary studies.